Trial Information
Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia
Inclusion Criteria:
- ASA status I-II patients
- aged 18 - 65 years
- scheduled for general surgery (except laparoscopic interventions) lasting longer than
1 hour.
Exclusion Criteria:
- Body weight < 70% or > 150% ideal body weight
- neurological disorder and hearing disorders (being not able to communicate with the
patient in a normal tone)
- use of any medication interfering with pharmacological effect of the study including
alcohol misuse or drugs.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Influence of AEP guided anesthesia on recovery delay
Principal Investigator
Michel STRUYS, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
CHU de GENT - BELGIUM
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
PEA
NCT ID:
NCT00181051
Start Date:
February 2003
Completion Date:
Related Keywords:
- Scheduled General Anesthesia